Search
for
Sort by
Research 241–270 of 410
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Fertility counseling and preservation: considerations for the pediatric endocrinologist
- Stereotactic Body Radiation Therapy As a Derivative of Stereotactic Radiosurgery: Clinically Independent But With Enduring Common Themes
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Incidence of alopecia in brain tumour patients treated with pencil scanning proton therapy and validation of existing NTCP models
- Cancer-Related Alopecia: From Etiologies to Global Management
- Therapies and nanotherapies for cervical cancer (Review)
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Zinc deficiency is associated with gynecologic cancer recurrence
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- South Asian Epidemic of Antifungal Therapeutic Failures: Congress Proceedings and Take-home Messages. First International Congress of SAARCUM: South Asian Alliance against Recalcitrant Cutaneous Mycosis. 17 November 2018, Medanta – The Medicity, Gurugram, India
- Porokeratotic Eccrine Ostial and Dermal Duct Nevus: A Report of Rare Late-Onset Solitary Lesion
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Melatonin protects K15+ human hair follicle stem cells and hair matrix keratinocytes against paclitaxel-induced damage ex vivo
- Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
- Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation
- Quality of Life in Slovak Breast Cancer Survivors: A Cross-Sectional Study Using EORTC QLQ-C30 and BR23
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data